The Future Of Life Sciences Manufacturing And The Supply Chain

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

We witnessed some amazing accomplishments by the biopharmaceutical industry last year.

Just think about all those clinical trials that were executed for the multiple vaccines that we now have access to in world-record time. But without the ability to: a) manufacture the supply necessary to conduct these trials, b) manage the transportation of these temperature-sensitive products to the point where they need to be administered, and c) scale up capacity to make the billions of doses necessary to inoculate the world, then nothing would have happened. In other words, the life sciences manufacturing and supply chains are everything when it comes to helping patients. In this edited transcript from our August 2021 executive virtual roundtable (EVR), perspectives on life sciences manufacturing and the supply chain are provided by Bryan Butman, Ph.D., head of CMC, Precigen; Louise Perry, SVP tech ops, Solid Biosciences; and Tim Valko, head of global manufacturing supply chain, Atara Biotherapeutics.